henhaobio
Sign in

bioRxivPharmacology & Toxicology

Vacuolar H+-ATPase subunit a was identified as the target protein of the oomycete inhibitor fluopicolide

T. Dai, J. Yang, C. Zhao, C. Zhang, Z. Wang, Q. Peng, P. Liu, J. Miao, X. Liu

PDFDOIPreprint

Abstract

Approximately 240 fungicides are currently in use. However, only a few direct targets have been identified, which limits the development of fungicides and rapid resistance monitoring. Fluopicolide, which is an excellent oomycete inhibitor, is classified as delocalization of spectrin-like proteins inhibitors by FRAC. In the current study, a Pc-actinin knockout had no effect on the sensitivity of Phytophthora capsici to fluopicolide. The vacuolar H+-ATPase subunit a (PcVHA-a) was identified using a BSA-seq and DARTS assay. Four kinds of point mutations in PcVHA-a that cause fluopicolide resistance in P. capsici were confirmed using site-directed mutagenesis. The results of MST, molecular docking, and a DARTS assay indicated that PcVHA-a could bind fluopicolide. Sequence analysis and a molecular docking assay proved the specificity of fluopicolide to oomycetes or fish. Our results suggest that PcVHA-a is the target of fluopicolide, and H+-ATPase could be used as a novel target for the development of new fungicides.

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.